FTCD p.Glu508Ter
c.1522G>T · VCV3587701
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | nonsense (stop-gain) | predicted loss-of-function |
|---|---|---|
| NMD | escapes | premature termination codon within the last 50 nt of the penultimate exon (13 of 14, 17 nt from its 3' end) — the truncated protein is likely expressed. PVS1 input, not an applied code |
| REVEL | 0.149 | moderately benign-leaning |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP -0.39 | GERP -1.2 |
| Overall | ||
| CADD | 35.0 | PHRED · no single calibrated threshold — expert panels disagree |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.0016% | 62,476 |
| European (non-Finnish)grpmax | 0.00136% | 73,703 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- FTCD
- Protein
- p.Glu508Ter
- Coding
- c.1522G>T
- MANE Select
- NM_206965
- Type
- single nucleotide variant
- Location
- chr21:46137256 (GRCh38)
- Gene constraint
- LOEUF 1.61 · pLI <0.01 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 95.30
- Residue 508
- the 'cyclodeaminase/cyclohydrolase' region
Disease context
formiminoglutamic aciduria — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Formiminoglutamic aciduria (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Childhood
Similar variants
- FTCD p.Glu508Lys Uncertain significance ★ ⚠ same residue
- FTCD p.Arg255Ter Pathogenic ★★ same condition
- FTCD p.Arg71Ter Pathogenic/Likely pathogenic ★★ same condition
- FTCD p.Leu536Ter Pathogenic/Likely pathogenic ★★ same condition
- FTCD p.Ala108Thr Uncertain significance ★★ ⚠ same condition
- FTCD p.Ala159Val Uncertain significance ★★ ⚠ same condition
- FTCD p.Ala368Val Uncertain significance ★★ ⚠ same condition
- FTCD p.Ala418Thr Uncertain significance ★★ ⚠ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ftcd-p-glu508ter (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown